Report
Fatma Agnès Hamdani

Glanbia : H1 2023 results unlikely to contain any surprises, marked by the fall in volumes and the upturn in profitability of GPN

>GPN: SlimFast continues to act as a drag in Q2 although less so than in Q1 - Glanbia is due to publish its interim results on 16 August. We are forecasting organic growth of 3.5% for GPN. Volumes will likely be down by an estimated 7%, with an improvement in Q2 vs Q1 (-9.5%). Volumes continued to be adversely affected by the further decline in Slimfast sales (delistings), against the backdrop of a persistently lacklustre US weight management market. The group expect...
Underlying
Glanbia Plc

Glanbia is a performance nutrition and ingredients group, engaged in providing performance nutrition, cheese, dairy ingredients, specialty non-dairy ingredients and vitamin and mineral premixes. Co. segments include: Global Performance Nutrition, which is involved in the branded performance nutrition business; Global Ingredients, which manufactures cheddar cheese, provides dairy and non-dairy nutritional ingredients and micro-nutrient premixes; Dairy Ireland, which is engaged in the manufacture and sale of a range of consumer products and farm inputs; and Joint Ventures & Associates, which is engaged in the manufacture and sale of cheese, dairy ingredients and dairy consumer products.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Fatma Agnès Hamdani

ResearchPool Subscriptions

Get the most out of your insights

Get in touch